Gene · 4154
Papers2,262
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,262
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Co-Opting MBNL-Dependent Alternative Splicing Cassette Exons to Control Gene Therapy in Myotonic Dystrophy. | Ann Neurol | 2026 | 40879030 | PubTator, text mining | PubMed |
| Changes in RNA splicing as a surrogate endpoint for myotonic dystrophy Type 1 (DM1) clinical trials. | J Neuromuscul Dis | 2026 | 40808372 | PubTator, text mining | PubMed |
| Bilingual Acquisition of Morphology: Norwegian and Russian Influence on Children's Sentence Repetition in Estonian. | Lang Speech | 2026 | 40302387 | PubTator, text mining | PubMed |
| Quantification of Interactions between Small Molecules and RNA Probes Representative of Myotonic Dystrophy Type 1 Using Affinity Capillary Electrophoresis and UPLC-UV. | ACS Omega | 2025 | 41510137 | PubTator, text mining | PubMed |
| An RBPMS-driven splicing regulatory axis including MBNL1, RBFOX2, and QK promotes smooth muscle cell contractile identity. | Nucleic Acids Res | 2025 | 41428739 | PubTator, text mining | PubMed |
| Integrated Transcriptomic and Biochemical Analyses Reveal the Root Development-Promoting Mechanism of Piriformospora indica on Blueberry Under Tap Water Irrigation. | Plants (Basel) | 2025 | 41375356 | PubTator, text mining | PubMed |
| A Live-Cell NanoBRET Assay to Monitor RNA-Protein Interactions and Their Inhibition by Small Molecules. | ACS Cent Sci | 2025 | 41341060 | PubTator, text mining | PubMed |
| The implications of alternative splicing regulation for maximum lifespan. | Nat Commun | 2025 | 41285791 | PubTator, text mining | PubMed |
| Characterization of DMPK and MBNL1 expression in cell models of myotonic dystrophy: a platform for drug screening. | NAR Mol Med | 2025 | 41256290 | PubTator, text mining | PubMed |
| Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1. | J Cachexia Sarcopenia Muscle | 2025 | 41250834 | PubTator, text mining | PubMed |
| Widespread prevalence of CD19 exon 5-6 skipping in primary pediatric B-Cell acute lymphoblastic leukemia patients. | Mol Cell Pediatr | 2025 | 41247554 | PubTator, text mining | PubMed |
| Freshwater Lamellidens marginalis as sentinels of TBTCl toxicity: Changes in the shell composition and biomarker response index. | Environ Monit Assess | 2025 | 41128957 | PubTator, text mining | PubMed |
| Multi-omics identification of RNASE6 as an immune regulatory RNA-binding protein associated with melanoma metastasis. | Autoimmunity | 2025 | 41055424 | PubTator, text mining | PubMed |
| Identification and analysis of the expansin gene family in yam. | PeerJ | 2025 | 41048382 | PubTator, text mining | PubMed |
| The Implications of Alternative Splicing Regulation for Maximum Lifespan. | bioRxiv | 2025 | 41040401 | PubTator, text mining | PubMed |
| Angel wing: a class of alternative splicing regulators in animals. | Nucleic Acids Res | 2025 | 41002027 | PubTator, text mining | PubMed |
| AEnet: a practical tool to construct the splicing-associated phenotype atlas at a single cell level. | Gigascience | 2025 | 40990037 | PubTator, text mining | PubMed |
| Discovery of RNA-Reactive Small Molecules Guides the Design of Electrophilic Modules for RNA-Specific Covalent Binders. | J Am Chem Soc | 2025 | 40951988 | PubTator, text mining | PubMed |
| A spatial long-read approach at near-single-cell resolution reveals developmental regulation of splicing and polyadenylation sites in distinct cortical layers and cell types. | Nat Commun | 2025 | 40883294 | PubTator, text mining | PubMed |
| Discovery of RNA-Targeting Small Molecules: Challenges and Future Directions. | MedComm (2020) | 2025 | 40859960 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4154/papers?page=3